Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
34
INKT Quote, Financials, Valuation and Earnings
Last price:
$12.20
Seasonality move
:
-18.07%
Day range:
$11.66 - $12.27
52-week range:
$4.56 - $76.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
14.4K
Avg. volume:
20.6K
1-year change:
122.52%
Market cap:
$56.5M
Revenue:
--
EPS (TTM):
-$3.03
Earnings Data
Next earnings date for INKT
Mar 17
2026
Most recent earnings per share
-$0.65
Beat by $0.21
(Nov 14/2025)
Consensus Estimate
-$0.86
(Nov 14/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
INKT Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/17/2026 | Q4 | -- | -- | -- | -$0.68 | -- |
| 11/14/2025 | Q3 | -- | -- | -$0.65 | -$0.86 | $0.21 |
| 08/14/2025 | Q2 | -- | -- | -$1.06 | -$0.55 | -$0.52 |
| 05/13/2025 | Q1 | -- | -- | -$0.70 | -$0.61 | -$0.09 |
| 03/18/2025 | Q4 | -- | -- | -$0.62 | -$0.50 | -$0.12 |
| 11/14/2024 | Q3 | -- | -- | -$0.05 | -$0.80 | $0.75 |
| 08/13/2024 | Q2 | -- | -- | -$0.07 | -$0.97 | $0.89 |
| 05/14/2024 | Q1 | -- | -- | -$0.11 | -$1.53 | $1.42 |
| 03/21/2024 | Q4 | -- | -- | -$0.16 | -$1.53 | $1.38 |
| 11/09/2023 | Q3 | -- | -- | -$0.15 | -- | -- |
| 08/10/2023 | Q2 | -- | -- | -$0.18 | -- | -- |
| 05/11/2023 | Q1 | -- | -- | -$0.17 | -- | -- |
| 03/21/2023 | Q4 | -- | -- | -$0.23 | -- | -- |
| 11/03/2022 | Q3 | -- | -- | -$0.19 | -- | -- |
| 08/09/2022 | Q2 | -- | -- | -$0.18 | -- | -- |
| 05/10/2022 | Q1 | -- | -- | -$0.23 | -- | -- |
| 03/18/2022 | Q4 | -- | -- | -$0.17 | -- | -- |
| 11/29/2021 | Q3 | -- | -- | -$0.59 | -- | -- |
| 06/30/2021 | Q2 | -- | -- | -$2.23 | -- | -- |
| 03/31/2021 | Q1 | -- | -- | -$0.12 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | -$0.54 | -- | -- |
| 09/30/2020 | Q3 | -- | -- | -$2.13 | -- | -- |
MiNK Therapeutics, Inc. Earnings Questions
-
How Much did MiNK Therapeutics, Inc. Generate in Revenue Last Quarter?
MiNK Therapeutics, Inc. reported -- worth of top line sales in its most recent quarter.
-
Did MiNK Therapeutics, Inc. Beat Earnings Last Quarter?
MiNK Therapeutics, Inc. announced earnings per share of -$0.65 which represents a beat of analyst forecast a -$0.86 per share.
-
Is MiNK Therapeutics, Inc. Profitable?
MiNK Therapeutics, Inc. reported -$43.7K that represents -$0.01 per share over the last quarter.
-
What is the Analyst Consensus for MiNK Therapeutics, Inc. EPS Next Year?
MiNK Therapeutics, Inc.'s earnings are forecast to decrease from -$2.86 per share to -$2.67 per share next year representing a decrease of -7.41%.
-
When is MiNK Therapeutics, Inc.'s Earnings Date?
MiNK Therapeutics, Inc.'s next earnings date is March 17, 2026.
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
60
AAOI alert for Dec 24
Applied Optoelectronics, Inc. [AAOI] is up 5.1% over the past day.
Buy
85
HUT alert for Dec 24
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Buy
63
GPCR alert for Dec 24
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.
